Standout Papers

Bimekizumab versus Secukinumab in Plaque Psoriasis 2021 2026 2022 2024214
  1. Bimekizumab versus Secukinumab in Plaque Psoriasis (2021)
    Kristian Reich, Richard B. Warren et al. New England Journal of Medicine

Immediate Impact

1 from Science/Nature 60 standout
Sub-graph 1 of 19

Citing Papers

Dynamic GelMA/DNA Dual‐Network Hydrogels Promote Woven Bone Organoid Formation and Enhance Bone Regeneration
2025 Standout
Evolving understanding of autoimmune mechanisms and new therapeutic strategies of autoimmune disorders
2024 Standout
8 intermediate papers

Works of Luke Peterson being referenced

Bimekizumab versus Secukinumab in Plaque Psoriasis
2021 Standout
Bimekizumab versus Adalimumab in Plaque Psoriasis
2021
and 2 more

Author Peers

Author Last Decade Papers Cites
Luke Peterson 917 450 160 456 59 1.2k
Yin You 953 324 129 456 33 1.1k
A.B. Gottlieb 1102 369 212 531 33 1.4k
Yoshinori Umezawa 823 245 148 531 70 1.3k
Marco Galluzzo 987 205 197 681 81 1.3k
Melodie Young 1003 217 231 555 40 1.3k
Alessandro Giunta 750 244 106 417 77 1.3k
Darryl Toth 1161 312 272 918 33 1.7k
Pierre‐Dominique Ghislain 665 407 332 604 36 1.4k
Marta Ferrán 906 259 175 626 79 1.4k
Chuanbo Zang 379 582 109 321 40 1.2k

All Works

Loading papers...

Rankless by CCL
2026